{"id":77,"date":"2017-08-12T20:07:01","date_gmt":"2017-08-12T20:07:01","guid":{"rendered":"http:\/\/liverresearchunit.org\/?page_id=77"},"modified":"2022-10-27T07:40:12","modified_gmt":"2022-10-27T07:40:12","slug":"focused-research-strategies","status":"publish","type":"page","link":"https:\/\/liverresearchunit.org\/?page_id=77","title":{"rendered":"RESEARCH STRATEGIES"},"content":{"rendered":"<h2><strong><span style=\"color: #ff0000;\">Identification<\/span><span style=\"color: #ff0000;\"> of critical pathways involved in liver cancer<\/span><\/strong><\/h2>\n<p><strong>Identification of non-coding RNAs signature impacting hepatocellular carcinoma in patients and 2D\/3D cell culture system based on liver cancer cells, stellate cells and Kupffer cells to identify molecular pathways related to induction\/progression of cancer, interaction with co-morbidities and response to treatment. The in vitro studies are specifically addressed to the identification of the alteration of regulatory cell signaling leading to autophagy or apoptosis (endoplasmic reticulum stress, ROS and RNS, Nrf2, inflammasome and mTOR), antiproliferative and pro-differentiation properties induced by tyrosine kinase inhibitor and immune check points.<\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-88\" src=\"http:\/\/liverresearchunit.org\/wp-content\/uploads\/2017\/08\/Oncogenesis_1-300x225.jpg\" alt=\"\" width=\"415\" height=\"311\" srcset=\"https:\/\/liverresearchunit.org\/wp-content\/uploads\/2017\/08\/Oncogenesis_1-300x225.jpg 300w, https:\/\/liverresearchunit.org\/wp-content\/uploads\/2017\/08\/Oncogenesis_1-326x245.jpg 326w, https:\/\/liverresearchunit.org\/wp-content\/uploads\/2017\/08\/Oncogenesis_1-80x60.jpg 80w, https:\/\/liverresearchunit.org\/wp-content\/uploads\/2017\/08\/Oncogenesis_1.jpg 567w\" sizes=\"auto, (max-width: 415px) 100vw, 415px\" \/><\/p>\n<p><a href=\"http:\/\/liverresearchunit.org\/wp-content\/uploads\/2022\/10\/Hallmarks.tif\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-435\" src=\"http:\/\/liverresearchunit.org\/wp-content\/uploads\/2022\/10\/Hallmarks.tif\" alt=\"\" width=\"1\" height=\"1\" \/><\/a><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-435\" src=\"http:\/\/liverresearchunit.org\/wp-content\/uploads\/2022\/10\/Hallmarks.tif\" alt=\"\" width=\"1\" height=\"1\" \/><\/p>\n<h2><strong><span style=\"color: #ff0000;\">Development of nanomedicine-based antitumoral strategies<\/span><\/strong><\/h2>\n<p><strong>The group develop therapeutic strategies related to the nanotechnology-based modifications of Sorafenib in order to increase its solubility in water, evasion from the reticuloendothelial system, increase the permeation and retention, and selectively treatment of HCC. The group develops functional in vitro and in vivo studies of Sorafenib integrated in glyconanosomes, glyconanomicelles photopolymerizable and carbon glyconanotubules biocompatible with the phototermic ablation.<\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-43\" src=\"http:\/\/liverresearchunit.org\/wp-content\/uploads\/2017\/08\/Sorafenib_Glycolipids-300x200.jpg\" alt=\"\" width=\"413\" height=\"275\" srcset=\"https:\/\/liverresearchunit.org\/wp-content\/uploads\/2017\/08\/Sorafenib_Glycolipids-300x200.jpg 300w, https:\/\/liverresearchunit.org\/wp-content\/uploads\/2017\/08\/Sorafenib_Glycolipids-768x511.jpg 768w, https:\/\/liverresearchunit.org\/wp-content\/uploads\/2017\/08\/Sorafenib_Glycolipids-1024x681.jpg 1024w, https:\/\/liverresearchunit.org\/wp-content\/uploads\/2017\/08\/Sorafenib_Glycolipids.jpg 1757w\" sizes=\"auto, (max-width: 413px) 100vw, 413px\" \/><\/p>\n<p><strong><span style=\"color: #339966;\">Institute of Biomedicine of Sevilla (IBiS)<\/span><\/strong><br \/>\n<strong><span style=\"color: #339966;\">Laboratory 209<\/span><\/strong><br \/>\n<strong><span style=\"color: #339966;\">Hospital University \u00abVirgen del Roc\u00edo\u00bb<\/span><\/strong><br \/>\n<strong><span style=\"color: #339966;\">Avda. Manuel Siurot s\/n<\/span><\/strong><br \/>\n<strong><span style=\"color: #339966;\">E-41013, Sevilla, Spain<\/span><\/strong><br \/>\n<strong><span style=\"color: #339966;\">Phone: (+34)-955-923122 (Office), (+34)-955-923121 (Lab)<\/span><\/strong><br \/>\n<strong><span style=\"color: #339966;\">e-mail: jmuntane-ibis@us.es<\/span><\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-365 size-medium\" src=\"http:\/\/liverresearchunit.org\/wp-content\/uploads\/2020\/05\/IMG_3149_reducida-300x189.jpg\" alt=\"\" width=\"300\" height=\"189\" srcset=\"https:\/\/liverresearchunit.org\/wp-content\/uploads\/2020\/05\/IMG_3149_reducida-300x189.jpg 300w, https:\/\/liverresearchunit.org\/wp-content\/uploads\/2020\/05\/IMG_3149_reducida-1024x645.jpg 1024w, https:\/\/liverresearchunit.org\/wp-content\/uploads\/2020\/05\/IMG_3149_reducida-768x484.jpg 768w, https:\/\/liverresearchunit.org\/wp-content\/uploads\/2020\/05\/IMG_3149_reducida-1536x968.jpg 1536w, https:\/\/liverresearchunit.org\/wp-content\/uploads\/2020\/05\/IMG_3149_reducida-2048x1291.jpg 2048w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<div class=\"mh-excerpt\"><p>Identification of critical pathways involved in liver cancer Identification of non-coding RNAs signature impacting hepatocellular carcinoma in patients and 2D\/3D cell culture system based on <a class=\"mh-excerpt-more\" href=\"https:\/\/liverresearchunit.org\/?page_id=77\" title=\"RESEARCH STRATEGIES\">[&#8230;]<\/a><\/p>\n<\/div>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-full.php","meta":{"footnotes":""},"class_list":["post-77","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/liverresearchunit.org\/index.php?rest_route=\/wp\/v2\/pages\/77","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/liverresearchunit.org\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/liverresearchunit.org\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/liverresearchunit.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/liverresearchunit.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=77"}],"version-history":[{"count":14,"href":"https:\/\/liverresearchunit.org\/index.php?rest_route=\/wp\/v2\/pages\/77\/revisions"}],"predecessor-version":[{"id":438,"href":"https:\/\/liverresearchunit.org\/index.php?rest_route=\/wp\/v2\/pages\/77\/revisions\/438"}],"wp:attachment":[{"href":"https:\/\/liverresearchunit.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=77"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}